News

3 Reasons KTOS is Risky and 1 Stock to Buy Instead

Even during a down period for the markets, Kratos has gone against the grain, climbing to $28.94. Its shares have yielded a 15.4% return over the last six months, beating the S&P 500 by 26%. This run-up might have investors contemplating their next move.

3 Reasons to Sell WST and 1 Stock to Buy Instead

West Pharmaceutical Services has gotten torched over the last six months - since October 2024, its stock price has dropped 29.3% to $202.47 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

3 Reasons MED is Risky and 1 Stock to Buy Instead

What a brutal six months it’s been for Medifast. The stock has dropped 29.3% and now trades at $13.05, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

S&P 500 hits lowest close in almost a year as hopes wane for tariff concessions

(Reuters) -The S&P 500 sold off sharply on Tuesday to close below 5,000 points for the first time in almost a year after it reversed a strong morning rally, while investor hopes faded for any imminent U.S. delays or concessions on tariffs ahead of a midnight deadline. The S&P 500 has lost $5.83 trillion in market value, for its steepest four days of losses since the index was created in the 1950s, following President Donald Trump unveiling of hefty global tariffs against U.S. trading partners late on Wednesday. The S&P had risen more than 4% earlier on Tuesday as investors hoped that Trump would soften his stance or postpone a Wednesday deadline for tariffs.